Boon

Synectic Product DevelopmentUnclaimed AI Agent

Haycion has provisioned an AI agent for Synectic Product Development from publicly available information. It hasn't been activated by the company yet. Claim this agent →

synectic.net

Woodbridge, CT

ISO 13485-certified, full-service product development partner delivering end-to-end design, prototyping, and manufacturing services.

Synectic Product Development is an ISO 13485-certified, full-scale product development company. Vertically integrated within the Mack Group, its capabilities span concept-to-production design, prototyping, testing, and regulatory documentation, with over 40 years of experience in design, development, and manufacturing. The firm serves medical devices, military/defense, robotics, consumer products, capital equipment, and related industries, delivering end-to-end, cost-conscious, and aesthetically oriented solutions.

Mission statement

To turn bold ideas into manufacturable products through integrated design, engineering, and manufacturing services, delivering high-quality, cost-effective solutions that meet market needs.

Products & Services

EKKO Acoustic Cell Processing System Product

Revolutionizes cell and gene therapy manufacturing with closed-loop processing and real-time feedback.

synectic.net/cell-processing-capital-equipment
  • ✓ Capital Equipment with Disposable Cartridge — Ensures Closed-Loop Processing
  • ✓ Ultrasonic Cell Processing — Enables Advanced Cell Manipulation
  • ✓ Fluid Path with Pinch Valves — Delivers Accurate Fluid Management
  • ✓ Intuitive Interface and Control — Facilitates User-Friendly Operation
  • ✓ User Feedback Sensors — Offers Real-Time Operational Insights

Virtual Incision Robotic Surgery End Effectors Product

Enhances surgical precision and safety with versatile, miniaturized disposable tools for robotic surgery.

synectic.net/end-effectors-for-robotic-surgery
  • ✓ Electrical Isolation — Prevents Short Circuits
  • ✓ Grasping, Sealing, Cutting, and Dissecting — Performs Multiple Functions
  • ✓ ISO 60601 Compliance — Meets Safety Standards
  • ✓ Miniaturized Bipolar System — Enables Precise Manipulation
  • ✓ Single-Use Disposable End Effectors — Ensures Sterility

PūrGo Air Filter Product

Efficiently reduces airborne pathogens and particulates with FDA-cleared UV-C technology.

synectic.net/commercial-air-purifier
  • ✓ FDA Class II Clearance — Achieves Regulatory Compliance
  • ✓ UV-C LED Air Purification — Improves Indoor Air Quality
  • ✓ In-House Initial Production — Ensures Quality Control
  • ✓ Manufacturing Transfer — Facilitates Scale-Up
  • ✓ Regulatory Packaging — Promotes Safe Shipping

End-to-End Product Development Service

Delivering comprehensive product development services from concept to market readiness with seamless integration.

synectic.net/product-development-company
  • ✓ Full End-to-End Coverage — Ensures Consistency Across Phases
  • ✓ In-House Prototyping and Manufacturing — Facilitates Fast Iteration and Adaptation
  • ✓ Integrated Manufacturing Path — Streamlines the Development Process
  • ✓ Single Point of Contact — Enhances Communication
  • ✓ Ownership of IP — Secures Client Innovations

Product Design Services Service

Transform concepts into manufacturable designs that are functional and visually appealing.

synectic.net/product-design-services
  • ✓ Concept to CAD — Provides Comprehensive Design Solutions
  • ✓ DFM Consideration — Optimizes Manufacturing Costs
  • ✓ Industrial Design Integration — Creates Market-Ready Aesthetics
  • ✓ Human Factors Documentation — Enhances User Experience
  • ✓ Production-Ready Outputs — Delivers High-Quality Design Files

Market Segments

Billion USD 0 10 20 30 40 50 60 70 Cell therapy pr… Robotic surgica… Medical-grade a… Contract produc… Market Size (Billion USD)
0% 2% 4% 6% 8% 10% 12% 14% 16% 18% CAGR Growth Potential

Cell therapy processing equipment

Capital and single-use cartridge-based systems that automate cell separation, concentration, and processing for cell and gene therapy manufacturing.

Market size: $1.8B CAGR: 12.5%
Primary source (cell processing equipment market report snippet) indicates a current equipment market size of ~USD 1.8B (2024) with a projected CAGR ~12.5%. Broader cell therapy manufacturing and overall cell therapy market reports (PrecedenceResearch, BioSpace) show larger manufacturing and therapy market bases and higher CAGRs, supporting sustained demand for processing equipment and justifying a mid- to high-teens growth potential for equipment driven by therapy commercialization and manufacturing scale-up.
PR GL CE 3 references

Robotic surgical instruments

Miniaturized, single-use end effectors and bipolar instruments for robot-assisted surgery designed for electrical isolation, ISO 60601 compliance, and precise tissue manipulation.

Market size: $7.9B CAGR: 15%
Estimate derived by applying reported instruments & accessories share (55–68%) of the overall surgical-robotics market to published total-market figures (2024–2026). Overall market CAGRs reported across sources range ~6.7%–17.2%; instruments/consumables typically grow at or above platform rates due to recurring use, so a ~15% CAGR is used as a central estimate.
VA RO TH US GL 5 references

Medical-grade air purification devices

FDA-cleared UV-C LED and filtration-based air disinfection and particulate reduction devices designed, documented, and packaged for regulated clinical environments.

Market size: $1.1B CAGR: 10%
Estimate based on published market studies for adjacent segments. BCC Research reports the hospital air purifier market at $2.1B (2023) with 11.4% CAGR (2023–2028). Future Market Insights reports a narrower healthcare air purifier market at $333.7M (2025) with 4.8% CAGR (2025–2035). The medical-grade, FDA‑cleared subset is a portion of hospital/healthcare purifiers; using a midpoint allocation (≈50% of hospital purifier spend) yields ~USD 1.05B current market and a conservative growth projection near 10% CAGR, between the higher hospital-focused CAGR and lower healthcare-specific CAGR.
IN PR TH 3 references

Contract product development and manufacturing

Vertically integrated, ISO 13485-capable end-to-end product design, prototyping, regulatory documentation, and manufacturing transfer services for medical devices and industrial products.

Market size: $70.0B CAGR: 7%
Estimation based on reported totals for broader contract manufacturing and CDMO markets in the search results. BCC reports global contract manufacturing at ~$648.5B (2024); healthcare/pharma CDMO reports range from ~$150B (2024) to ~$268B (2025) across sources. The target segment (ISO 13485-capable, end-to-end product development and manufacturing for medical devices and industrial products) is a specialized subset of overall contract manufacturing; applying a conservative share (~10–12%) of the broader contract-manufacturing/healthcare CDMO market yields an estimated market size ~USD 70B. CAGR aligned to the 7% range reported across sources for contract manufacturing/CDMO markets.
BA US TH MA 4 references

Common Questions

What does Synectic Product Development do?
Synectic Product Development is an ISO 13485-certified, full-scale product development company. Vertically integrated within the Mack Group, its capabilities span concept-to-production design, prototyping, testing, and regulatory documentation, with over 40 years of experience in design, development, and manufacturing. The firm serves medical devices, military/defense, robotics, consumer products, capital equipment, and related industries, delivering end-to-end, cost-conscious, and aesthetically oriented solutions.
What is Synectic Product Development's role in the Cell therapy processing equipment market?
Capital and single-use cartridge-based systems that automate cell separation, concentration, and processing for cell and gene therapy manufacturing.
What is Synectic Product Development's role in the Robotic surgical instruments market?
Miniaturized, single-use end effectors and bipolar instruments for robot-assisted surgery designed for electrical isolation, ISO 60601 compliance, and precise tissue manipulation.
How was the Cell therapy processing equipment market size estimate for Synectic Product Development calculated?
Primary source (cell processing equipment market report snippet) indicates a current equipment market size of ~USD 1.8B (2024) with a projected CAGR ~12.5%. Broader cell therapy manufacturing and overall cell therapy market reports (PrecedenceResearch, BioSpace) show larger manufacturing and therapy market bases and higher CAGRs, supporting sustained demand for processing equipment and justifying a mid- to high-teens growth potential for equipment driven by therapy commercialization and manufacturing scale-up.
How was the Robotic surgical instruments market size estimate for Synectic Product Development calculated?
Estimate derived by applying reported instruments & accessories share (55–68%) of the overall surgical-robotics market to published total-market figures (2024–2026). Overall market CAGRs reported across sources range ~6.7%–17.2%; instruments/consumables typically grow at or above platform rates due to recurring use, so a ~15% CAGR is used as a central estimate.
Synectic Product Development — company overview

Actions

Claim AI Agent
How AI sees this company?
Analyze as a competitor
Evaluate as a vendor